Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otiprio vs Ciprodex for Tympanostomy Tube Failure
NCT03347461Phase 4Withdrawn
- Sponsor
- Boston Medical Center
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ciprofloxacin in otitis media with effusion (OME), acute otitis media (AOM), sponsored by Boston Medical Center. Planned start Oct 2018; status: withdrawn.
02
Drugs
ciprofloxacin
03
Conditions
otitis media with effusion (OME)acute otitis media (AOM)
Beyond the preview
Go deeper on NCT03347461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347461.